Philippe Plattet
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Nanobody-based canine PD-L1-targeting immune checkpoint inhibitors for cancer therapy in dogs.
Journal: Molecular therapy. Oncology
Published: January 09, 2025
Protection against lethal canine distemper virus infection by a dual epitope-targeting synthetic antibody.
Journal: Nature communications
Published: December 02, 2024
Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation.
Journal: JCI insight
Published: July 27, 2023
Functional Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Delivered by Canine Histiocytic Sarcoma Cells Persistently Infected with Engineered Attenuated Canine Distemper Virus.
Journal: Pathogens (Basel, Switzerland)
Published: June 05, 2023
Structure and supramolecular organization of the canine distemper virus attachment glycoprotein.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2023
LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus.
Journal: mBio
Published: January 16, 2023
Persistent Infection of a Canine Histiocytic Sarcoma Cell Line with Attenuated Canine Distemper Virus Expressing Vasostatin or Granulocyte-Macrophage Colony-Stimulating Factor.
Journal: International journal of molecular sciences
Published: April 14, 2022
Efficient recovery of attenuated canine distemper virus from cDNA.
Journal: Virus research
Published: March 07, 2022
Selective SLAM/CD150 receptor-detargeting of canine distemper virus.
Journal: Virus research
Published: February 17, 2022
Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance.
Journal: EMBO reports
Published: October 21, 2021
Last Updated: 09/26/2026